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If early intervention leads to better outcome
can ‘earliest’ intervention prevent progress to
frank psychosis or Delay it?
Clinical
Epidemiological
Neuropsychological
Neurophysiological
Neuroimaging
Animal Studies

Cognitive Neurosciences
Clinical studies of Early
Psychosis initiative

‘At-Risk for Psychosis’
Challenges
Significant public health merit
Unfolding brain development & maturation in SZ.
specificity in Non-specific symptoms
Consensus in Definitions & Measurements
Predictive validity of symptoms & Risk factors
Biomarkers & behavioral markers of regional brain
dysfunction
• Argument for Intervention: when & how?
•
•
•
•
•
•

Opening up windows of opportunities for
identification & treatment
• ‘ How operationally benign the process
was….”(McGlashan)
• Need to refine identification in adolescents
• Refining the criteria's prevention
• Medication trial = Medication free challenge
• Ongoing functional decline
• Suicide
• Homicide or risk

Genetics , familial,
Environmental Risk

Genetic High risk group (GHR)
Clinical High Risk Group ( CHR)
Ultra High Risk group ( UHR)

PET imaging showing areas of brain activity in twins - one schizophrenic, one not.
Image courtesy Dr. Karen Berman, Clinical Brain Disorders Branch, NIMH, NIH)

Childhood Experience and the
Expression of Genetic Potential:
What Childhood Neglect Tells Us
About Nature and Nurture 1, 2

1.Chen TJ, Med Hypotheses. 2006;66(5):1043-4.
2.Anda RF,Eur Arch Psychiatry Clin Neurosci. 2006 Apr;256(3):174-86. 2005

Neuronal
development &
Child abuse

Commonly described prodromal features of
schizophrenia (modified from Yung, 2006)
Neurotic symptoms

Changes in volition

• Anxiety
• Restlessness
• Anger, irritability

• Apathy, loss of drive
• Boredom, loss of interest
• Fatigue, reduced energy

Mood-related symptoms

Cognitive changes

• Depression
• Anhedonia
• Guilt
• Suicidal ideas
• Mood swings

• Disturbance of attention and
• concentration
• Preoccupation, daydreaming
• Thought blocking
• Reduced abstraction

Young AY& Mcgorry PD, Prediction of Psychosis: setting the stage, BJP 2007, 191 suppl 51

Symptoms suggesting high risk
Physical symptoms

Attenuated or sub-threshold versions of psychotic
symptoms 1, 2

Somatic complaints

Perceptual abnormalities

Loss of weight

Suspiciousness

Poor appetite

Ideas of reference

Sleep disturbance

Change in sense of self, others
or the world

Behavioral changes
Other symptoms
Obsessive–compulsive phenomena
Dissociative phenomena
Increased interpersonal sensitivity

Deterioration in role functioning
Social withdrawal
Impulsivity
Odd behavior
Aggressive, disruptive behavior

The prodrome concept runs into problem Variability, lack of specificity 3
1.Tien, A.Y. (1991) Distributions of hallucinations in the population. Social Psychiatry and Psychiatric Epidemiology, 26, 287-292.
2.van Os, J.,Hanssen,M., Bijl, R.V., et al (2001) Prevalence of psychotic disorder and community level of psychotic symptoms: An urban-rural comparison. Archives of General Psychiatry, 58, 663668.
3.Young AY& Mcgorry PD, Prediction of Psychosis: setting the stage, BJP 2007, 191 sp 51

UTILITY OF A CLINICAL STAGING MODEL1
(e.g. malignancy ) QOL & Survival depends upon earliest possible intervention

 fundamental assumptions
 early stages better response
 treatments offered likely benign & effective.2
Stage 0
Increased risk of psychotic disorder
• No symptoms currently

Stage 1b
Ultra-high risk: moderate but subthreshold
symptoms, with moderate neurocognitive
changes and functional decline.

Stage 1a
Mild or non-specific symptoms, including
neurocognitive deficits Mild functional change
or decline

Stage 2
First episode of psychotic disorder Full
threshold disorder with moderate^ severe
symptoms, neurocognitive deficits and
functional decline (Global Assessment of
Functioning (GAF) 30-50)

1.Young AY& McGorry PD, Prediction of Psychosis: setting the stage, BJP 2007, 191 sp 51
2.McGorry, P.D.,Hickie, I. B.,Yung, A. R., et al (2006) Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective
interventions. Australia and New Zealand Journal of Psychiatry, 40, 616^622.

Stage 3b

Stage 3a
Incomplete remission from
first episode of care

Stage 3c
Multiple relapses,
provided
worsening in clinical extent and
impact of illness is objectively
present

Recurrence or relapse of psychotic
disorder which stabilizes with
treatment at a level of GAF, residual
symptoms, or neurocognition below
the best level achieved following
remission from first episode

Stage 4.
Severe,persistentor unremitting illness as
judged on symptoms, neurocogntion and
disability criteria
Note: could fast track to this stage at first
presentation through specific clinical and
functional criteria (from stage 2) or alternatively
by failure to respond to treatment

Young AY& Mcgorry PD, Prediction of Psychosis: setting the stage, BJP 2007, 191 sp 51

(from stage 3a

Level 0, No Psychiatric Symptoms

Detect sub threshold
symptoms
Psychotic-like-experiences
(PLE)

Level 1 PLEs No distress ,
Help seeking, poor
functioning,
co morbidity
Level 2
other Psychiatric
syndromes with
incidental PLE
Level 3,
PLEs associated with Distress,
help-seeking, reduced
functioning, Comorbidity,
Level 4
First episode psychosis, frank
Symptoms
Level 5
Schizophrenia

Substance use
Cannabis : contrasting results,
‘role of cannabis as a risk for onset of psychosis’.
Prospective studies : ‘.SU contribute to the onset’ 1
‘irrespective’ of identified risk
Cannabis use increases likelihood of psychotic relapse 2
Increased psychotic experiences –in non-clinical general population 3
Neither use nor dependence ( 1 year prior ) -- associated with higher risk
in F/U 1 Y
• High levels use  less motivated to seek Tx. 4
• Edinburgh study,: ‘more likely to have psychotic-like symptoms at
baseline’ 5
• No longitudinal data for transition to psychosis
•
•
•
•
•

1.Hornicroft, 1990, 2.Linszen et al, 1994), 3.Johns et al, 2004 (PACE cohort ) 4.Phillips et al, 2002a, 5.Miller et al, 2001

Stress
Adverse Life Events ( ALE)
• Precede onset 1
• Cause Relapses in established
disorders 2
• Hypothesis: ALE may actually
precipitate onset in vulnerable
individuals.
• Minor life events or day-to-day
hassles: are more stressful than
major events 3
• Subjective experiences of stress,

• More intense negative
affect to subjective
appraisals 4
• Difference in tolerance
– psychotic like symptoms
– lifetime experience of major
stressors in prodromal & UHR, 5
– significant association: ‘impaired
tolerance of normal stress’ and
psychosis onset in UHR 6.

1.Bebbington et al, 1993, 2.Hirsch et al, 1996
3.Malla & Norman, 1992 , 4.Myin-Germeys et al (2001) 5. Miller et al, 2001), 6. Yung et al, 2005

Social Functioning
•
•
•
•
•
•
•
•
•
•

• Clinical High Risk subjects consistently
demonstrate deficits equivalent to those
seen in FE subjects in
– current social functioning
– premorbid social functioning
– social cognition
• facial affect recognition
• social judgments
Addington et al. 2008 Brit J Psych;
Addington et al. 2008 Schiz Res
•
•

Addington et al. 2008 Brit J Psych;
Addington et al. 2008 Schiz Res

Social Functioning, social cognition 1,2
• Both UHR & GHR show
impairment,
• UHR > GHR
• Duration of prodromal
symptoms UHR– related impaired
• PS & NS - not significant
• Both a trait and state marker
of risk schizophrenia /

•
•
•
•

1.Shim G Social functioning deficits in young people at risk for
schizophrenia.
, Aust N Z J Psychiatry. 2008 Aug;42(8):678-85

psychotic disorders,
Mediating vulnerability
Early indicator,
Prodromal stage- modest
impairment
Prefrontal dysfunction

2.Chung YS, Deficit of theory of mind in individuals at ultrahigh-risk for schizophrenia
. Schizophr Res. 2008 Feb;99(1-3):111-8.

The theory of social defeat explains
affective appraisal & response for
environmental factors enhancing
risk for schizophrenia
Marginalization, Social exclusion, Physical
& Sex Abuse, Migration, Ethnicity increase
prevailing risk level

Social defeat, Environment & Enhanced
Risk of SZ
•

•

Previously, - proposed theory: Longterm experience of social defeat,
defined as a subordinate position or
as outsider status, may well be the
common denominator for these
findings 1
This interpretation is compatible
with the
 High levels of competition in urban areas,
 Fewer career opportunities for people
with low IQ,
 Social exclusion experienced by
immigrants and people with hearing
impairments and
 The humiliation of being abused

1.Selten & Cantor-Graae, 2005. 2.Thewissen et al, 2005 3.Read et al, 2005

• Not Purely-Genetic risk
factors:
• urban environment,
migration,
• low IQ,
• hearing impairment 2
• use of illicit drugs.
• Physical & sexual abuse 3

Search for Bio-markers
• Abnormal body movements, correlated with prodromal
symptoms ( dopamine effect)
• Tendency to interpret nonsensical babbling as words and
phases
• ‘ tendency to read meaning into meaningless sensory
information may produce ‘ matrix of unreality’ that prompts
initial psychotic phase.

Reduction in Mismatch negativity amplitude MMN &
Heschl’s gyrus reduction
Seen in chronic state
Not seen in FES ( Umbricht et al 2006)
Reduced by NMDA
Involvement of auditory cortex in pathogenesis ( Salisbury et
al 2007) schizophrenia
• Pathological changes are not confined to specific brain
regions, PFC
•
•
•
•

Prodromal Syndrome
assessment tools
• Identification by a structures interview
– Structured interview for prodromal syndrome (SIPS)
– Comprehensive Assessment of At Risk mental state (
CAARMS)
– Bonn scale for assessment of basic symptoms ( BSABS

• Syndromes
– Attenuated positive symptom syndrome
– Brief intermittent psychotic syndrome
– Genetic risk + deterioration syndrome

Variable Transition Rates
Study

N

Current
average

Rate (%)

Follow-up (
months

33%

PACE (Aus)

104

35

12

PRIME (Yale)

13

54

12

PRIME (NA)

60

35

12

RAP (NY)

34

27

6

EDIE (UK)

23

22

12

CARE (SD)

50

15

12

Toronto

50

20

12

PAS,
Newcastle,
AUS

50

12

TOPP, Norway

43

12

Manchester
(UK)

22

12

PACE (Aus),
2006

9.2

6

• Declining TR @ 0.8 times at
PACE(1995-2000)
• Explained by:
• a- reduction in duration of
symptom prior to help,
• b-more false positive

Survival distribution function in North
American study

6

12

18

Cannon et al. Arch Gen Psychiatry 2008;65:28-37

24

30

Transition Rate or
Conversion to Psychosis depends upon the
vulnerability of selected group
• Status Natural untreated transition in
heterogeneous risk group
• Status of Preventable transition by a
treatment (Non-drug or drug therapy)
• Selection is criteria dependent which
leads to variability in transition rate.

NAPLS
“… prospective ascertainment of .. At risk for
psychosis is feasible, with a level of predictive
accuracy comparable to that in other areas of
medicine”.. Tyrone Cannon
• N=291, F/U 30 months, 8 centers, tallied 77 individual
predictors variables at base.
• Variables covered 10 domains
• 5 additional criteria over SIPS increased chances of prediction
by 80%
• 35% TR, RR 405 in general population.

UHR Status (CAARMS)
• Sensitive (92%)predictor (TR 12/13 )
• Specificity was 62% Low functioning – as a
predictor
Intervention

Late transition :
ineffective treatment + risk

Early transition:
Severe progression

pathogenesis

4-6 weeks

Measurement of social and role functioning for
assessment of UHR is challenging
•
•
•
•
•
•

Cornblatt et al : two scales
1. Global Scale of functioning: Social
2.Global Scale of functioning: Role
Excellent interrater reliability
Functional decline as a risk
Functional improvement – a
prognostic indicator in UHR

Psychosis

Good
functioning

Poor
functioning

Inability to
cope with
Psychotic
experience

Community initiative & experience
‘highlight the need for comprehensive universal public mental
health interventions’.

• Educational campaign for destigmatization in a
comparative study, Oslo, Norway:
• Drop in suicidal behavior
• Age at first contact- reduced , younger with milder
symptoms
• Shorter DUP

Do Cognitive Deficits Progress During the
Course of Schizophrenia? Yes, on all parameters

Cognition declines as psychosis progresses
At-risk

*
*

Global Cognitive measure
*

*
FES

*

*
*

Linear
CSZ
Time Line

* *

*

*

*
*

Cognitive Deficits
Cognitive performance profiles
intermediate to normal control and first
episode psychosis cohorts across domains
of attention, memory and executive ability.
Degree of deficit at base does not predict psychosocial
outcome.
The course of change in follow up does does differentiate good &
poor functional outcome

Neurocognitive impairment in UHR
1.Working memory, 2.Executive Functioning
Represent neurocognitive trait as markers for SZ.
Working memory, - consistently impaired throughout the course 1
Working memory - impaired prior to the onset of psychotic illness 2
Immediate verbal recall deficits - prior to illness onset, indicate
compromised prefrontal functioning.
 Olfactory identification deficits - occur prior to psychosis onset 3.
 despite this, --- predictive value of neurocognitive variables has
proved to be disappointingly poor.
•




1. Goldman-Rakic, 1994, 2. Brewer et al, 2005, 3.(Brewer et al, 2001).

Profile of Change in Mean Cognition

Whether cognitive function declined over the
transition to psychosis?





The origin of CI- unclear.
some deficits are apparent prior to the onset
if subjects with CI progress. unknown
there may be a specific decline in visual memory and




attentional set-shifting, reflecting impairments in efficient
organization of visual stimuli.

This may be caused by either the illness itself or treatment
with antipsychotic medication.

Wood SJ, Cognitive decline following psychosis onset: data from the PACE clinic
Br J Psychiatry Suppl. 2007 Dec;51:s52-7 .

Neurobiological- HPA
dysfunction may play a role
 Higher cortisol levels
 Abnormal circadian cortisol
rhythms Kaneko et al, 1992).
• N=12 UHR participants
• Combined dexamethasone
corticotrophin releasing hormone
(DEX/CRH) test (Thompson et al,
2007).
• Over a 2-year, 3 of the 12
participants developed psychosis.

•

•

participants who did not make
the transition
–  higher cortisol levels,
– Greater severity of
depression- anxiety
symptoms.
Dysregulated HPA-axis in UHR
may represent ‘ comorbid
depression’ rather than factors
for process of emerging psychosis

Neuroplasticity provides foundation for
possibility ‘re-generating’ neurons
Hypertrophy of brain Regions using cognitive functions
Navigation expertise and the human hippocampus: A structural brain imaging analysis
Eleanor A. Maguire: the experiment of London Taxi Drivers

Intensive Computer based cognitive
mediation as therapeutic
intervention: NIHM Study

Impaired Neuroplasticity in Schizophrenia and the
Neuro-regenerative
•
•

•
•

•

FES : progressive loss of cortical and
subcortical gray matter 1-6
childhood-onset SZ, cortical volume
loss: 1%-3% per year during the first 5
years.7
High risk for SZ: brain tissue loss during•
the transition.8
Assumed –it was due to
– brain atrophy,
– neurotoxicity, or
– neurodegeneration that involved
– loss of neurons in the gray matter.
However, it has become apparent brain
volume loss was due to:
– shrinkage of the neuropil

surrounding the neurons, 9
– reduction in dendrite length by a
half
– decrease in number and size of
dendritic extensions.10,11
Furthermore,
– decline in neurotropin 3 (NT-3), 12
suggesting that
– brain tissue loss during psychosis
may be caused by a decline in
growth factors that are critical in
brain development,
neuroplasticity, and
– synaptic connectivity.

Imaging
Findings generally demonstrate structural
and functional changes post conversion
but no differences to aid prediction
Longitudinal increase in lateral ventricles, decrease in brain
volume
• White matter & grey matter changes
• Histropathological correlation?
•
•
•
•

Cavum septum pellucidum (CSP)
in High risk subjects
•
•
•
•

Abnormal (CSP) [ is a space between the two leaflets of the septum
pellucidum],
no significant correlations with symptoms.1
Reduced neurotransmitter function in CSP 2
NT activity is reduced in UHR (N-acetylaspartateThe NAA concentrations of the
UHR cases and FES -- correlated with the severity of negative symptoms). 2

1. Choi JS et al. Cavum septum pellucidum in subjects at ultra-high risk for psychosis: compared with first-degree relatives of patients with
schizophrenia and healthy volunteers. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jul 1;32(5):1326-30
2.Aydin K, Altered metabolic integrity of corpus callosum among individuals at ultra high risk of schizophrenia and first-episode patients. Biol
Psychiatry. 2008 Nov 1;64(9):750-7

Consensus findings
1.
2.
3.
4.

Dysfunction maturational
processes
loss of grey matter in DPFC
Aberrant mechanisms for brain
maturation,
Subtle regionally and temporally
specific changes through the
course of psychosis,
(1) Early (pre- and perinatal)

anomalies,
(2) around the time of transition
(3) Late (post-pubertal) changes
soon after the onset of psychosis,

• As yet there are no
convincing, replicated,
reports of neuroimaging
measures that predict the
subsequent onset of
psychosis.
• The relative failure of
neuroimaging measures to
predict transition to psychosis
suggests that standard volumetric
techniques are incapable of
capturing the subtle differences
UHR with different outcomes

• Instead the most promising
finding have been in Neuropsych. domain, with strong
evidence for impairments in
prefrontal cortex.

The brain developing in normal
healthy youth
COMT
regulates DA
turnover
NMDA Delays
Brain
Maturation

Time-lapse "movie" compresses 15 years of normal brain development (ages 5-20) into just a few seconds. Red indicates more gray matter, blue less
gray matter. Gray matter wanes in a back-to-front wave as the brain matures and neural connections are pruned. Areas performing more basic functions
mature earlier; areas for higher order functions mature later. The prefrontal cortex, which handles reasoning and other "executive" functions, emerged
late in evolution and is among the last to mature.
Source: Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC, Nugent TF 3rd, Herman DH, Clasen LS, Toga AW, Rapoport
JL, Thompson PM. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A.
2004 May 25;101(21):8174-9. Epub 2004 May 17. PMID: 15148381

The brain developing in childhood onset schizophrenia
Time-Lapse MRI movie shows the brain developing in 12 teens with childhood onset schizophrenia. Areas of gray matter loss - red and yellow
— spread from back-to-front over 5 years. These teens lost gray matter in the prefrontal cortex at 4 times the rate of normal health teens

Source: Thompson PM, Vidal C, Giedd JN, Gochman P, Blumenthal J, Nicolson R, Toga AW, Rapoport JL. Mapping adolescent brain change
reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11650-5.
PMID: 11573002

Five Key Predictors
‘Poorer the social function & the more severe the unusual thought content &
suspiciousness, closer was the person to onset of psychosis”

•
•
•
•
•

Genetic risk with recent deterioration in function.
Higher levels of unusual thoughts
Higher level of suspicion or paranoia.
Greater social impairment
History of substance abuse

Intervention
Should Antipsychotics be used in Prodromal phase or at-risk SZ
McGorry et al.,
2002, AGP
Melbourne

Morrison et al.,
2004, BJP
Manchester

McGlashan et al.,
2006, AJP
North America

6 month FU 12 month FU
12 month FU
N=59

12 months F/U
N=58

12 months F/U
N=60

10% -Risperidone & CBT
36% -needs based

9%-CBT
22-30% monitoring

16% - Olanzapine
35% - Placebo

42% stopped
risperidone

Dropout 13% for CBT, 14%
for monitoring

Dropout – 55% for
Olanzapine, 355 for
Placebo

Three published studies : may be able to delay or
even prevent onset of psychosis.

Preventive Family intervention; Expressed Emotion (EE)
• Predictive of psychotic relapse (Bebbington & Kuipers,1994)
• ‘Not an artefact of patient morbidity’ (Leff and Vaughn,1995)
• ‘Family intervention is recommended to reduce relapse risk’
(NICE, 2003)

1.Specific therapy V. need-based therapy (McGorry)
2. CONCLUSIONS: Without a specific treatment, 30-60% of
persons with UHR develop frank psychosis,
3.Low-dose antipsychotic treatment seems to be effective
4. in Prevention or
5. delay of psychosis.

McGorry PD, Yung AR Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis
in a clinical sample with subthreshold symptoms, Arch Gen Psychiatry. 2002 Oct;59(10):921-8

Cognitive therapy
Vs. monitoring :
• only conducted by the Early
Detection and Intervention (EDIE)
group Manchester showed a
significant effect of the
treatment.
Treatment
Group
Cognitive
Therapy (N = 35)
Monitoring
(N = 23)

Morrison et al, 2004

Follow-up Rate
N (%)

PANNS
Transition
N (%)

Antipsychotic
Medication
N (%)

17 (49%)

7 (20%)

5 (14%)

DSM-IV
Psychotic
Diagnosis
N (%)
7 (20%)

10 (43%)

5 (22%)

8 (35%)

7 (30%)

Second-Generation Antipsychotics
• In contrast to haloperidol, several SGAs were reported to
stimulate
• Neurogenesis in the adult rat, except for clozapine, which
according to 2 reports has no effect.
• Studies with olanzapine have shown:
• Increased neurogenesis in the hippocampus
• Increased hippocampal neurogenesis after 28 days
• No change in the hippocampus but an increased proliferation in
the prefrontal cortex,
• This result indicate: A delay in the onset of psychosis
•

‘Olanzapine

versus
supportive therapy and
monitoring
•
•
•

showed a trend
in effectively preventing
or delaying psychosis
(McGlashan et al, 2006).

• In all, results of these first
treatment trials suggest that both
• Tx Gr.- lower levels of
antipsychotic
‘Prodromal’ Symptomatology
medication and psychological
• the clinical benefit, terms of
interventions might have a role in
transition rates, was more
treating the difficulties and
equivocal.
problems young people at ultrahigh risk experience as well as
Yung AR, Yuen
HP,onset
Aust N Z J Psychiatry. 2005 Nov-Dec;39(11-12):964-71.
delaying or preventing
the
of psychosis.

Conclusion
• Identification & prediction involve using different
combinations of genetic, age range and symptomatic risk
factors.
• However, even using these multiple-gate screening models,
the majority of those selected still do not develop the
disorder.
• This aids our detection of individuals in whom indicated
preventive intervention may be justified.
• Arriving at a PPV of 100% would be a clear indication for
pharmacological treatment in the identified group.

